Breaking News

Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here

Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Merrimack Pharmaceuticals Inc (MACK)

NASDAQ

Add to/Remove from Watchlist Add to Watchlist

5.490 -0.070 -1.26%

27/05 - Closed. Currency in USD ( Disclaimer )

Type: Equity

Market: United States

ISIN: US5903282094

CUSIP: 590328209

Volume: 15,489
Bid/Ask: 0.000 / 0.000
Day's Range: 5.300 - 5.620

News
Analysis & Opinion

MACK Analysis

This page features the latest analysis and reports for the Merrimack Pharmaceuticals Inc stock.

What Makes Merrimack Pharmaceuticals (MACK) A Strong Sell? By Zacks Investment Research - Aug 29, 2016

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are...

Merrimack (MACK) Q2 Loss Wider Than Expected, Sales Top By Zacks Investment Research - Aug 05, 2016

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) reported a loss of 40 cents per share in the second quarter of 2016, wider than the Zacks Consensus Estimate of 34 cents. Quarter in Detail Total...

Merrimack (MACK): Can The Stock Surprise In Q2 Earnings? By Zacks Investment Research - Aug 01, 2016

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is scheduled to report second-quarter 2016 results on Aug 4. Last quarter, Merrimack delivered an earnings surprise of +15.38%. Let’s see how...

Merrimack Pharmaceuticals: Trade On Breakout By António Costa - Jul 31, 2016

Merrimack Pharmaceuticals Inc (NASDAQ:MACK) is a candidate to be traded in breakout mode next week. The Daily technical indicators are looking better for the stock with MACD indicator above its sell...

Celgene's Revlimid Gains EU Nod For Mantle Cell Lymphoma By Zacks Investment Research - Jul 18, 2016

Positive news flowed in at Celgene Corporation (NASDAQ:CELG) when the European Commission approved a label expansion of Revlimid. With the label expansion, Revlimid can now be used for the treatment...

ZIOPHARM (ZIOP) Stock Down On Patient Death In Phase I By Zacks Investment Research - Jul 17, 2016

ZIOPHARM Oncology, Inc.’s (NASDAQ:ZIOP) shares crashed 11.6% after the company announced the death of a patient in a phase I study on its lead candidate, Ad-RTS-hIL-12, for the treatment of...

Gilead's HCV Drug Epclusa Gets Regulatory Nod In Canada By Zacks Investment Research - Jul 14, 2016

Gilead Sciences Inc. (NASDAQ:GILD) announced that Health Canada has issued a Notice of Compliance to Epclusa (Sovaldi 400 mg/velpatasvir 100 mg), the first once-daily, pan-genotypic single-tablet...

Ultragenyx (RARE) Reports Positive Phase III RhGUS Data By Zacks Investment Research - Jul 14, 2016

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced positive top-line data from a pivotal phase III study on recombinant human beta-glucuronidase (rhGUS) for the treatment of...

CytRx (CYTR) Stock Falls On Unfavorable Aldoxorubicin Data By Zacks Investment Research - Jul 13, 2016

CytRx Corporation’s (NASDAQ:CYTR) shares plunged 59.8% after the company announced unfavorable initial results from a phase III study on its lead candidate, aldoxorubicin, in the treatment of...

Comeback For Juno (JUNO) Stock? FDA Lifts Clinical Hold By Zacks Investment Research - Jul 13, 2016

Is immuno-oncology focused Juno Therapeutics, Inc. (NASDAQ:JUNO) , set for a comeback? The company, which saw its shares falling 31.9% last week, looks poised for a recovery with the FDA removing the...

1 2 3 4 5

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

MACK Comments

Write your thoughts about Merrimack Pharmaceuticals Inc

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

JD Pete Dec 02, 2020 12:54PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Good time to buy

3 0

Report

Bob Malbranche Sep 11, 2018 10:08AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

strong buy

2 0

Report

Daniyar Dzhangelov May 30, 2017 8:16AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

time to buy

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200952539">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200952539" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200952539">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200952539">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	33,278.1	+640.9	+1.96%
US 500	4,169.4	+111.6	+2.75%
Dow Jones	33,212.96	+575.77	+1.76%
S&P 500	4,158.24	+100.40	+2.47%
Nasdaq	12,131.13	+390.48	+3.33%
S&P 500 VIX	25.72	-1.78	-6.47%
Dollar Index	101.653	-0.205	-0.20%

Crude Oil WTI	115.07	+0.98	+0.86%
Brent Oil	115.32	+1.15	+1.01%
Natural Gas	8.708	-0.187	-2.10%
Gold	1,851.64	+4.04	+0.22%
Silver	22.130	+0.165	+0.75%
Copper	4.3225	+0.0635	+1.49%
US Soybeans	1,732.50	+6.00	+0.35%

SPDR S&P 500	415.26	+9.95	+2.45%
iShares Russell 2000	187.64	+4.92	+2.69%
Invesco QQQ Trust	309.10	+9.77	+3.26%
Direxion Daily Junior Gold Miners Bull 2X Shares	53.41	+0.46	+0.87%
iShares Silver	20.36	+0.05	+0.25%
ProShares Ultra VIX Short-Term Futures	14.21	-0.88	-5.83%
ProShares UltraPro QQQ	33.29	+2.97	+9.80%

Apple	149.64	+5.86	+4.08%
Alphabet A	2,246.33	+90.48	+4.20%
Tesla	759.63	+51.90	+7.33%
Amazon.com	2,302.93	+81.38	+3.66%
Netflix	195.19	+3.79	+1.98%
Meta Platforms	195.13	+3.50	+1.83%
Bank of America	37.02	+0.35	+0.95%

Recent Quotes

	Name	Price	Chg.	Chg. %
	MACK	5.490	-0.070	-1.26%

Market Movers

Name	Last	Chg. %	Vol.
AMD	102.26	+3.55%	103.91M
AAPL	149.64	+4.08%	90.30M
NVDA	188.11	+5.38%	72.97M
TSLA	759.63	+7.33%	29.29M
MSFT	273.24	+2.76%	26.63M
FB	195.13	+1.83%	22.38M
AMZN	2,302.93	+3.66%	4.50M

Name	Last	Chg. %	Vol.
PDD	48.30	+15.19%	31.70M
ZS	160.00	+12.57%	6.76M
ULTA	425.08	+12.47%	2.76M
ADSK	211.38	+10.31%	2.98M
DDOG	98.07	+9.42%	6.54M
MRNA	147.66	+8.73%	7.59M
MPWR	455.85	+8.11%	544.30K

Name	Last	Chg. %	Vol.
WDAY	158.79	-5.57%	13.36M
BMY	76.14	-1.87%	15.04M
PM	106.97	-1.02%	6.95M
CF	95.72	-1.02%	4.03M
KDP	35.18	-0.99%	11.41M
C	53.62	-0.87%	19.25M
ZBH	119.83	-0.68%	922.43K